Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
ACN新闻在线能提供全方位的服务。对于希望向媒体、业界和金融市场披露和传播信息的公司和组织,我们能为您安排实时的新闻发布。ACN新闻在线的新闻稿包括英文、简体中文、繁体中文、韩文和日文等多种语言版本。
Monday, 30 November 2020, 14:00 HKT/SGT
Share:

来源 China Shineway Pharmaceutical Group Limited
神威药业 (02877.HK) 十月份单月营业额比去年同期录得29.4%增长

香港, 2020年11月30日 - (亚太商讯)  - 神威药业(股份代號:02877.HK)於二零二零年十月份单月营业额比去年同期录得29.4%增长,其中注射液产品、软胶囊产品、颗粒剂产品、中药配方颗粒、及其他剂型产品营业额分别上升了38.9%, 17.4%,38.1%,7.9%,及 54.0% 。

话题 Press release summary

部门 健康与医药
http://www.acnnewswire.com
From the Asia Corporate News Network

Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network


Latest Press Releases
CALB (3931.HK) Announced a Positive Profit Alert  
Feb 28, 2026 11:43 HKT/SGT
Unisound U1-OCR: The First Industrial-Grade Document Intelligence Foundation Model, Ushering in the OCR 3.0 Era  
Feb 28, 2026 09:00 HKT/SGT
NEC Strengthens Multi-Vendor Optical Network Solutions with New TIP-Certified Phoenix Hardware Lineup  
Friday, February 27, 2026 5:50:00 PM
NEC Demonstrates Agentic AI-Driven Autonomous Network Operations in Collaboration with AWS  
Friday, February 27, 2026 4:31:00 PM
Mitsubishi Heavy Industries Compressor Acquires Swiss Rotating Equipment Maintenance Company AST Turbo AG  
Friday, February 27, 2026 4:23:00 PM
NEC Strengthens Its Edge Portfolio for the 6G Era, Enabling Efficient Edge Deployment and Integration with Cloud Services  
Friday, February 27, 2026 11:24:00 AM
Fujitsu POS solution enhances customer experience at Hankyu Hanshin Department Stores  
Friday, February 27, 2026 11:03:00 AM
Casa Minerals Announces 2026 Aggressive Exploration Plans for Congress Gold Mine and Arsenault Projects  
Feb 26, 2026 21:59 HKT/SGT
Mitomo Semicon Engineering to Change Company Name  
Thursday, February 26, 2026 9:00:00 PM
Truecaller Partners with AnyMind Group to Expand Direct Sales Footprint Across MENA and Southeast Asia  
Feb 26, 2026 20:20 HKT/SGT
More Press release >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
顶部 | 关于我们 | 服务 | 合作伙伴 | 联系人 | 隐私权政策 | 使用条款 | RSS
美国: +1 214 890 4418 | 中国: +86 181 2376 3721 | 香港: +852 8192 4922 | 新加坡: +65 6549 7068 | 东京: +81 3 6859 8575